Anticoagulant Therapy and Bleeding‐Related Hospitalizations in Patients With Cancer: A National Cohort Study
Open Access
- 7 September 2026
- journal article
- other
- Published by Wiley in American Journal of Hematology
- Vol. 101 (12) , 3047-3051
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Risk factors for anticoagulant-related bleeding in cancer: traditional and cancer-specific factorsBlood Vessels, Thrombosis & Hemostasis, 2025
- Association between anticoagulant-related bleeding and mortality in patients with hematological malignancies and cancer-associated venous thromboembolismThrombosis Research, 2025
- Association Between Anticoagulant‐Related Bleeding and Mortality in Patients With Solid Tumors and Cancer‐Associated Venous ThromboembolismAmerican Journal of Hematology, 2025
- Atrial fibrillation and cancer: prevalence and relative risk from a nationwide studyResearch and Practice in Thrombosis and Haemostasis, 2023
- Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019JAMA Oncology, 2021
- Assessment of ICD‐10‐CM code assignment validity for case finding of outpatient anticoagulant‐related bleeding among Medicare beneficiariesPharmacoepidemiology and Drug Safety, 2019
- Assessment of the coding accuracy of warfarin-related bleeding eventsThrombosis Research, 2017
- Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2014
- Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapyJournal of Thrombosis and Haemostasis, 2007
- Assessment of Vital Status in Department of Veterans Affairs National DatabasesAnnals of Epidemiology, 2001